Tengion (TNGN)
Tengion Revenues
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
Select a metric
Date range:
to
<Embed Chart>
Pro Save as Image
Pro Data Export
Copy the code below and paste
into the embed destination.
into the embed destination.
Attention
OK
About Revenues
Income that a company gains from business activities, calculated before any expenses are subtracted. Includes all sales and other increases in owner's equity.
Learn More
You may also be interested in these TNGN related companies
TNGN News
Tengion Provides Business Update and Reports First Quarter 2012 Financial Results
May 07, 4:05PM PR Newswire
May 07, 4:05PM PR Newswire
Tengion Announces IND Filing for Neo-Kidney Augment Expected During First Half of 2013
Apr 17, 4:08PM Benzinga
Apr 17, 4:08PM Benzinga
Tengion (TNGN) Applies for Transfer to Nasdaq Capital Market; Mulls Stock Split
Apr 03, 4:12PM Street Insider
Apr 03, 4:12PM Street Insider
Tengion Announces Listing Transfer from NASDAQ Global Market® to NASDAQ Capital Market®
Apr 03, 4:10PM PR Newswire
Apr 03, 4:10PM PR Newswire
$TNGN very surprised this didn't take off, my guess is it will be a gradual parabolic up like last quarter
about 66 days ago by shoot2thrill
about 66 days ago by shoot2thrill
$TNGN FYI last quarter they reported .26lps vs .48lps in 2010 and look what happened to the price.. now 1.13 lps vs 2.80lps is even better
about 67 days ago by shoot2thrill
about 67 days ago by shoot2thrill
$TNGN excellent news... this is going to rocket for sure
http://stks.co/35GM
about 67 days ago by shoot2thrill
about 67 days ago by shoot2thrill
Tengion Announces Significant Advances in Neo-Urinary Conduit and Neo-Kidney Augment Programs
Mar 26, 4:06PM Benzinga
Mar 26, 4:06PM Benzinga
Tengion Announces Significant Advances in Neo-Urinary Conduit™ and Neo-Kidney Augment™ Programs
Mar 26, 4:05PM PR Newswire
Mar 26, 4:05PM PR Newswire
Trading Radar for 03/26: Reed's (REED), Tengion (TNGN), Landex (LNDC), KIOR (KIOR) Report
Mar 23, 3:48PM Street Insider
Mar 23, 3:48PM Street Insider
$TNGN conference call on 3/26. Hopefully it's good news otherwise I'm bailing with a 33% loss.
http://stks.co/2ylF
about 73 days ago by shoot2thrill
about 73 days ago by shoot2thrill
$TNGN http://stks.co/1sqc 1hr view, watching for support to hold on the 50
about 142 days ago by Tr8r_x
about 142 days ago by Tr8r_x
RT @Safeguard $SFE #partnercompany $TNGN "Surges As Its Phase 1 Clinical Trial Continues" (via @StockPreacher) http://stks.co/1q1d
about 144 days ago by howardlindzon
about 144 days ago by howardlindzon
$SFE #partnercompany $TNGN "Surges As Its Phase 1 Clinical Trial Continues" (via @StockPreacher) http://stks.co/1q0j
about 144 days ago by Safeguard
about 144 days ago by Safeguard
Tengion Announces Relocation of Corporate Headquarters to Current Facility in Winston-Salem, North Carolina
Jan 05, 4:22PM PR Newswire
Jan 05, 4:22PM PR Newswire
Tengion Presents New Scientific Data in Presentations at TERMIS North America Annual Meeting
Dec 13, 8:30AM PR Newswire
Dec 13, 8:30AM PR Newswire
Tengion announces restructuring, will reduce workforce by approximately 58%
Nov 14, 4:35PM FlyOnTheWall
Nov 14, 4:35PM FlyOnTheWall
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| TNGN | 0.28 | -0.01 | -1.75% | 6.829M |
| TNE | 10.99 | +0.00 | +0.00% | 4.205B |
| TNDM | 13.57 | +0.13 | +0.97% | 426.71M |
| TNC | 40.96 | -1.24 | -2.94% | 797.58M |
| TNB | 71.99 | +0.00 | +0.00% | 3.758B |
| STD | 5.335 | +0.01 | +0.28% | 47.40B |
| STC | 13.47 | -0.36 | -2.60% | 267.33M |
| STB | 6.55 | -0.07 | -1.06% | |
| STAN | 18.65 | -0.36 | -1.89% | 296.94M |
| STAA | 8.24 | -0.25 | -2.94% | 307.34M |
